Live courses

Title Credit Costsort ascending Dates
NCCN Tumor Boards: Immune Checkpoint Inhibitors for First-Line Therapy in Esophagogastric/Esophagogastric Junction Cancer
    • 1.00 AAPA Category 1 CME credit
    • 1.00 CCM clock hours
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 Participation
 $0.00 10/21/2024 - 2:00pm to 3:00pm EDT
NCCN Pharmacy Updates: Novel Therapies for Treating ESR1 and RET-Fusion Mutations in Breast Cancer
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 Participation
 $0.00 10/29/2024 - 1:00pm to 2:00pm EDT
NCCN Pharmacy Updates: Chemoimmunotherapy Updates in Advanced/Metastatic Non-Small Cell Lung Cancer
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 Participation
 $0.00 11/06/2024 - 2:00pm to 3:00pm EST
NCCN Tumor Boards: Multidisciplinary Management of Head and Neck Cancers
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 CCM clock hours
    • 1.00 Participation
 $0.00 11/14/2024 - 11:30am to 12:30pm EST
NCCN Tumor Boards: New Approaches to Treatment of Bladder Cancer
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 CCM clock hours
    • 1.00 Participation
 $0.00 11/15/2024 - 11:00am to 12:00pm EST

Pages

Featured courses

Title Credit Type Event date Costsort ascending
NCCN Guidelines® Insights - Prostate Cancer, Version 3.2024
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
 Enduring $0.00
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    • 2.00 ANCC contact hours
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 ACPE contact hours
    • 2.00 AAPA Category 1 CME credit
    • 2.00 Participation
 Enduring $0.00
Bispecific Antibodies: A New Frontier in Immunotherapy
    • 0.75 ANCC contact hours
      • 0.75 ANCC Pharmacology Contact Hours
    • 0.75 Participation
 Enduring $0.00
Plenary Session - Promising Practices to Reduce the Impact of Drug Shortages on Cancer Care
    • 1.25 AAPA Category 1 CME credit
    • 1.25 ASWB continuing education credit
    • 1.25 ACPE contact hours
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC contact hours
    • 1.25 Participation
 Enduring $0.00
Renal Cell Carcinoma: Evolving Perspectives on Optimal Treatment
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
      • 1.00 ANCC Pharmacology Contact Hours
    • 1.00 Participation
 Enduring $0.00

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.